Skip to content

Clinical trials

Insulin Resistance trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Insulin Resistance Phase: Not applicable Clear all

1,533 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
200215
200314
200424
200533
200654
200745
200862
200979
201060
201174
201265
201366
201476
201570
201678
201761
201891
201968
202051
202160
202272
202374
202483
202571
202667

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed1,054
Unknown status164
Recruiting125
Terminated57
Active, not recruiting52
Withdrawn35
Not yet recruiting33
Enrolling by invitation7
Suspended6

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Maastricht University Medical Center40
University of Copenhagen33
University of Aarhus28
Pennington Biomedical Research Center21
Massachusetts General Hospital20
University Hospital Tuebingen16
University of Michigan15
Stanford University14
University of Alabama at Birmingham14
Washington University School of Medicine14

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Insulin Resistance1,533
Obesity403
Diabetes Mellitus, Type 2262
Diabetes Mellitus191
Metabolic Syndrome175
Overweight107
Glucose Intolerance93
Inflammation92
Prediabetic State82
Hyperglycemia58

Trials

Showing 76 to 100 of 1,533. Each trial links to its page on Pharma Observatory.

1,433 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.